References
- Singh RB, Kartikey K, Moshori M, Neki NS et al. Coenzyme Q10 in the treatment of heart and vascular disease. In: Dhalla NS, Choklingham A, Berkowitz HI, Singhal PK (eds) Frontiers of Cardiovascular Health. Boston: Kluwer Academic Publishers, 2003, 395–420.
- Bliznakov EG. Coenzyme Q10 in experimental infections and neoplasia. In: Folkers K, Yamamura Y (eds) Biochemical and Clinical Aspects of Coenzyme Q10. Amsterdam: Elsevier/North Holland Biomedical Press, 1977, 73–83.
- Bliznakov EG. Coenzyme Q10, the immune system and aging. In: Folkers K, Yamamura Y (eds) Biochemical and Clinical Aspects of Coenzyme Q10. Amsterdam: Elsevier/North Holland Biomedical Press, 1977, 311–323.
- Singh RB, Shinde SN, Chopra RK et al. Effect of coenzyme Q on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits. Atherosclerosis 2000; 148: 275–82.
- Bliznakov EG, Wilkins DJ. Biochemical and clinical consequences of inhibiting coenzyme Q10 biosynthesis by lipid lowering HMG-CoA reductase inhibitors (statins), a critical overview. Adv Therapy 1998; 15: 218–28.
- Reis F, Hermida RC, Souza I, Maldonado J, Tavares P, Fontes-Ribiero CA, Teixeira HM, Alcobia T, Almeida L, Teixeira F. Circadian and seasonal variation of endogenous ubiquinone plasma level. Chronobiology International 2002; 19: 599–614.
- Halberg F, CornZˇlissen G, Wang ZR, Wan C, Ulmer W, Katinas G, Singh Ranjana, Singh RK,Singh Rajesh, Gupta BD, Singh RB, Kumar A, Kanabrocki E, Sothern RB, Rao G, Bhatt MLBD, Srivastava M, Rai G, Singh S, Pati AK, Nath P, Halberg Francine, Halberg J, Schwartzkopff O, Bakken E, Shastri VK. Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond. J Exp Therapeutics Oncol 2003; 3: 223–60.